AzTrials
AzTrials

Chronic Low-back PainFRELOMBNCT04128098

Frequency of Correct Response and Factors Associated in the Medium Term With a Multimodal Rehabilitation Program for Chronic Low Back Pain

An observational study of Chronic Low-back Pain, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Non-specific chronic low back pain is defined as pain that originates in the lumbar spine, is persistent, lasts more than 3 months, and is unrelated to an inflammatory, traumatic, tumour, malformation, or infectious cause. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Low-back Pain
What is being tested?
Evaluation, Questionnaires and Rehabilitation care program
How many people
2 participants
Where
1 siteFrance
Study dates
24 Jan 2020to 23 Feb 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patient presenting for consultation in the re-education and rehabilitation department of the CHU Dijon Bourgogne

Who may be able to join

  • Adult patient
  • Having provided oral consent
  • Chronic non-specific low back pain (HAS2015 criteria)
  • Eligible for a rehabilitation program
  • Patient affiliated or benefiting from a social security scheme

Who cannot join

  • Adult unable to provide consent
  • Lumbar spine surgery scheduled in the coming year
  • Associated pathologies other than spinal (orthopedic, neurological, vascular, cardiac...) that can affect locomotion
  • Root damage with motor deficit <3
  • Altered comprehension skills making self-assessment impossible
  • Patient subject to a protective measure (guardianship, curatorship)
Show all 10Show fewer
  • Patient subject to a judicial protection
  • Pregnant, parturient or breastfeeding woman
  • Not fluent in French
  • Patient who has already completed a multimodal rehabilitation program

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Dijon Bourgogne

    Dijon, 21079

Other trials in France

About this study

Non-specific chronic low back pain is defined as pain that originates in the lumbar spine, is persistent, lasts more than 3 months, and is unrelated to an inflammatory, traumatic, tumour, malformation, or infectious cause. Chronic low back pain is one of the most frequent reasons for consulting a physician, and one of the most common sources of disability, particularly as a result of socio-professional withdrawl. It is a major consumer of health resources (diagnostic investigations, multiple treatments) and involves heavy expenses for the investigator's health insurance system. In view of this major public health issue, in November 2017, the Health Insurance and several specialized health organizations launched a "general public" campaign to raise awareness of low back pain. This campaign, entitled "Back pain? The right treatment is movement" was designed to encourage appropriate physical activity in patients with low back pain.

Among the available therapies, multimodal programs are recommended as a first line treatment. In order to incorporate physical activity into patients' daily lives, these rehabilitation programs are based on a comprehensive multidisciplinary approach (therapeutic education, muscle strengthening, reconditioning, ergonomics, psychological, social, professional and nutritional management and cardiovascular risk factors). Although such programmes have already shown short term effectiveness, few data are available on their continued effectiveness in the medium term (1 year). This project aims to identify good and bad responders to a multimodal program in the medium term, based on common clinical parameters (Quebec City questionnaire score and spontaneous walking speed), and to identify the mechanisms underlying this response.

In addition, in clinical practice, heterogeneity in maintaining the effectiveness of the program is observed but little documented. The limited data available show a heterogeneity of these programs and one of the objectives of this project will be to identify the existing barriers and levers available to improve this situation.

Being tested
Evaluation, Questionnaires, Rehabilitation care program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EvaluationOther

    • Functional tests: 400-meter walking test, 200-meter brisk walking test, Sorensen test, Shirado test, measurement of maximum isometric force of extensors/back flexors.
    • 3D analysis of locomotion and posture
    • Test of the flexion-relaxation phenomenon of the lumbar erector muscles
  • QuestionnairesOther

    Self-questionnaires: Oswestry, Québec, SF-12, VAS pain, HAD, pain dramatization questionnaire, physical activity questionnaires, VAS and GPE satisfaction, FABQ, GPE functional status and EPICES score.

  • Rehabilitation care programOther

    • Personalized global exercises (aerobics) on ergometers
    • Muscle strengthening with resistance
    • Balneotherapy
    • Learning health skills related to their condition (therapeutic education)
    • Personal and group motivational interviews
    • Nutritional advice
    • Relaxation session

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of good medium-term responders in a multimodal rehabilitation program

    Measured: M13 (12 months after the end of the program)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2019
  2. Study start24 Jan 2020
  3. Primary completion23 Feb 2021
  4. Study completion23 Feb 2021

Why it stopped: The Covid pandemic made it impossible to monitor and rehabilitate patients at the Dijon Bourgogne CHU's CCR. A new home rehabilitation programme was set up. This new rehabilitation programme rendered the study obsolete and the project was abandoned.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04128098
Sponsor's protocol ID
ORNETTI PCA 2018-2
Acronym
FRELOMB
Status last verified
Oct 2023
First submitted
14 Oct 2019
Last updated
16 Oct 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Low-back Pain, run by Centre Hospitalier Universitaire Dijon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 16 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: The Covid pandemic made it impossible to monitor and rehabilitate patients at the Dijon Bourgogne CHU's CCR. A new home rehabilitation programme was set up. This new rehabilitation programme rendered the study obsolete and the project was abandoned.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of good medium-term responders in a multimodal rehabilitation program (time frame: M13 (12 months after the end of the program)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in